An update on the toxicity of Aβ in Alzheimer’s disease

Jürgen Götz1, Lars M Ittner1, Nicole Schonrock1, Roberto Cappai21Alzheimer’s and Parkinson’s Disease Laboratory, Brain and Mind Research Institute, University of Sydney, NSW, Australia; 2Department of Pathology, The University of Melbourne, Victo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jürgen Götz, Lars M Ittner, Nicole Schonrock, Roberto Cappai
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/a5f855e5836944cf9e7885f9fdbf9170
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a5f855e5836944cf9e7885f9fdbf9170
record_format dspace
spelling oai:doaj.org-article:a5f855e5836944cf9e7885f9fdbf91702021-12-02T03:42:05ZAn update on the toxicity of Aβ in Alzheimer’s disease1176-63281178-2021https://doaj.org/article/a5f855e5836944cf9e7885f9fdbf91702008-12-01T00:00:00Zhttp://www.dovepress.com/an-update-on-the-toxicity-of-abeta-in-alzheimerrsquos-disease-a2710https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Jürgen Götz1, Lars M Ittner1, Nicole Schonrock1, Roberto Cappai21Alzheimer’s and Parkinson’s Disease Laboratory, Brain and Mind Research Institute, University of Sydney, NSW, Australia; 2Department of Pathology, The University of Melbourne, Victoria, AustraliaAbstract: Alzheimer’s disease is characterized histopathologically by deposition of insoluble forms of the peptide Aβ and the protein tau in brain. Aβ is the principal component of amyloid plaques and tau of neurofibrillary tangles. Familial cases of AD are associated with causal mutations in the gene encoding the amyloid precursor protein, APP, from which the amyloidogenic Aβ peptide is derived, and this supports a role for Aβ in disease. Aβ can promote tau pathology and at the same time its toxicity is also tau-dependent. Aβ can adopt different conformations including soluble oligomers and insoluble fibrillar species present in plaques. We discuss which of these conformations exert toxicity, highlight molecular pathways involved and discuss what has been learned by applying functional genomics.Keywords: amyloid, mitochondria, oligomer, proteomic, tau, transgenic Jürgen GötzLars M IttnerNicole SchonrockRoberto CappaiDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 6, Pp 1033-1042 (2008)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Jürgen Götz
Lars M Ittner
Nicole Schonrock
Roberto Cappai
An update on the toxicity of Aβ in Alzheimer’s disease
description Jürgen Götz1, Lars M Ittner1, Nicole Schonrock1, Roberto Cappai21Alzheimer’s and Parkinson’s Disease Laboratory, Brain and Mind Research Institute, University of Sydney, NSW, Australia; 2Department of Pathology, The University of Melbourne, Victoria, AustraliaAbstract: Alzheimer’s disease is characterized histopathologically by deposition of insoluble forms of the peptide Aβ and the protein tau in brain. Aβ is the principal component of amyloid plaques and tau of neurofibrillary tangles. Familial cases of AD are associated with causal mutations in the gene encoding the amyloid precursor protein, APP, from which the amyloidogenic Aβ peptide is derived, and this supports a role for Aβ in disease. Aβ can promote tau pathology and at the same time its toxicity is also tau-dependent. Aβ can adopt different conformations including soluble oligomers and insoluble fibrillar species present in plaques. We discuss which of these conformations exert toxicity, highlight molecular pathways involved and discuss what has been learned by applying functional genomics.Keywords: amyloid, mitochondria, oligomer, proteomic, tau, transgenic
format article
author Jürgen Götz
Lars M Ittner
Nicole Schonrock
Roberto Cappai
author_facet Jürgen Götz
Lars M Ittner
Nicole Schonrock
Roberto Cappai
author_sort Jürgen Götz
title An update on the toxicity of Aβ in Alzheimer’s disease
title_short An update on the toxicity of Aβ in Alzheimer’s disease
title_full An update on the toxicity of Aβ in Alzheimer’s disease
title_fullStr An update on the toxicity of Aβ in Alzheimer’s disease
title_full_unstemmed An update on the toxicity of Aβ in Alzheimer’s disease
title_sort update on the toxicity of aβ in alzheimer’s disease
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/a5f855e5836944cf9e7885f9fdbf9170
work_keys_str_mv AT jampuumlrgengampoumltz anupdateonthetoxicityofaampbetainalzheimeramprsquosdisease
AT larsmittner anupdateonthetoxicityofaampbetainalzheimeramprsquosdisease
AT nicoleschonrock anupdateonthetoxicityofaampbetainalzheimeramprsquosdisease
AT robertocappai anupdateonthetoxicityofaampbetainalzheimeramprsquosdisease
AT jampuumlrgengampoumltz updateonthetoxicityofaampbetainalzheimeramprsquosdisease
AT larsmittner updateonthetoxicityofaampbetainalzheimeramprsquosdisease
AT nicoleschonrock updateonthetoxicityofaampbetainalzheimeramprsquosdisease
AT robertocappai updateonthetoxicityofaampbetainalzheimeramprsquosdisease
_version_ 1718401688548671488